Companies / BOC Sciences / Necitumumab
BOC Sciences

Necitumumab | BOC Sciences

Necitumumab is a human IgG1 monoclonal antibody that binds to EGFR. Necitumumab has been approved for the treatment of squamous NSCLC.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More